vimarsana.com

Latest Breaking News On - Board of management dermapharm holding - Page 1 : vimarsana.com

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE s corporate strategy

EQS-News: Dermapharm Holding SE / Key word: Quarterly / Interim Statement/Quarter Results Strong organic growth in core markets underscores resilience of Dermapharm Holding SE s.

United statesSachsen anhaltMecklenburg vorpommernPharm gmbHans georg feldmeierBritta hambergerBoard of management dermapharm holdingArkopharma groupDermapharm holdingWellster healthtech group gmbDermapharm holding seInvestor relations corporate communicationsDermapharm groupWellster healthtech group gmbhPharmaceutical excellence

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

EQS-News: Dermapharm Holding SE / Key word: Annual Results/Annual Report Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges.

Sachsen anhaltUnited statesHans georg feldmeierBritta hambergerDermapharm holding seArkopharma groupDermapharm holdingBoard of management dermapharm holdingMeeting of dermapharm holdingFrench arkopharma groupInvestor relations corporate communicationsAnnual reportMiddle eastGeneral meetingAnnual general meetingSupervisory board

Dermapharm Holding SE builds on success in Q3 2023

EQS-News: Dermapharm Holding SE / Key word(s): 9 Month figures/Quarterly / Interim StatementDermapharm Holding SE builds on success in Q3 2023 15.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dermapharm Holding SE builds on success in Q3 2023   Consolidated r.

Sachsen anhaltUnited statesBritta hambergerHans georg feldmeierArkopharma groupPharmaceuticals gesetzDermapharm holding se keyBoard of management dermapharm holdingDermapharm holdingInvestor relations corporate communicationsDermapharm holding seDistribution servicesInterim statementGerman actMore safetyPharmaceutical excellence

Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall -Today at 01:32 am

EQS-News: Dermapharm Holding SE / Key word: Half Year Results/Half Year Report Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023.

Sachsen anhaltUnited statesHans georg feldmeierBritta hambergerGroup to friedrichsdorfArkopharma groupDermapharm holding seDermapharm holdingBoard of management dermapharm holdingInvestor relations corporate communicationsPharmaceutical excellence

Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall

EQS-News: Dermapharm Holding SE / Key word(s): Half Year Results/Half Year ReportDermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall 29.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dermapharm Holding SE publishes H1 2023 finan.

United statesSachsen anhaltHans georg feldmeierBritta hambergerInvestor relations corporate communicationsDistribution servicesBoard of management dermapharm holdingDermapharm holdingGroup to friedrichsdorfDermapharm holding se keyArkopharma groupDermapharm holding seHalf yearHalf year reportPharmaceutical excellenceCorporate news

vimarsana © 2020. All Rights Reserved.